Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Korean red ginseng is a specific processed form of Panax ginseng (Panax ginseng C.A. Meyer), a perennial plant native to East Asia and primarily cultivated in Korea[1][4]. The "red" designation refers to the traditional preparation method in which fresh Panax ginseng roots are steamed and dried, resulting in chemical changes that distinguish it from white (unprocessed) or other forms of the root[4]. The main active constituents are saponin glycosides known as ginsenosides (notably Rg1, Re, Rb1, Rc, R
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Korean red ginseng.